235 related articles for article (PubMed ID: 22057994)
41. Functional SNPs in the SCGB3A2 promoter are associated with susceptibility to Graves' disease.
Song HD; Liang J; Shi JY; Zhao SX; Liu Z; Zhao JJ; Peng YD; Gao GQ; Tao J; Pan CM; Shao L; Cheng F; Wang Y; Yuan GY; Xu C; Han B; Huang W; Chu X; Chen Y; Sheng Y; Li RY; Su Q; Gao L; Jia WP; Jin L; Chen MD; Chen SJ; Chen Z; Chen JL
Hum Mol Genet; 2009 Mar; 18(6):1156-70. PubMed ID: 19126779
[TBL] [Abstract][Full Text] [Related]
42. The association of interleukin-1alpha and interleukin-1beta polymorphisms with the risk of Graves' disease in a case-control study and meta-analysis.
Liu N; Li X; Liu C; Zhao Y; Cui B; Ning G
Hum Immunol; 2010 Apr; 71(4):397-401. PubMed ID: 20116409
[TBL] [Abstract][Full Text] [Related]
43. CTLA-4 gene polymorphism and its association with Graves' disease in the Lebanese population.
Nakkash-Chmaisse H; Makki RF; Abdelhamid E; Fakhoury H; Salti NN; Salti I
Eur J Immunogenet; 2004 Jun; 31(3):141-3. PubMed ID: 15182328
[TBL] [Abstract][Full Text] [Related]
44. Screening of SNPs at 18 positional candidate genes, located within the GD-1 locus on chromosome 14q23-q32, for susceptibility to Graves' disease: a TDT study.
Chistiakov DA; Savost'anov KV; Turakulov RI
Mol Genet Metab; 2004 Nov; 83(3):264-70. PubMed ID: 15542398
[TBL] [Abstract][Full Text] [Related]
45. Gender-dependent and age-of-onset-specific association of the rs11675434 single-nucleotide polymorphism near TPO with susceptibility to Graves' ophthalmopathy.
Kuś A; Szymański K; Jurecka-Lubieniecka B; Pawlak-Adamska E; Kula D; Miśkiewicz P; Bolanowski M; Płoski R; Bossowski A; Daroszewski J; Jarząb B; Bednarczuk T
J Hum Genet; 2017 Mar; 62(3):373-377. PubMed ID: 27829681
[TBL] [Abstract][Full Text] [Related]
46. IL-18 gene polymorphism confers susceptibility to the development of anti-GAD65 antibody in Graves' disease.
Hiromatsu Y; Mukai T; Kaku H; Miyake I; Ichimura M; Fukutani T; Nakayama H; Takata K; Imamura Y; Shoji S; Yamada K; Koda Y; Bednarczuk T
Diabet Med; 2006 Feb; 23(2):211-5. PubMed ID: 16433722
[TBL] [Abstract][Full Text] [Related]
47. Association of polymorphisms of rs179247 and rs12101255 in thyroid stimulating hormone receptor intron 1 with an increased risk of Graves' disease: A meta-analysis.
Gong J; Jiang SJ; Wang DK; Dong H; Chen G; Fang K; Cui JR; Lu FE
J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):473-479. PubMed ID: 27465319
[TBL] [Abstract][Full Text] [Related]
48. CD8+CD28-lymphocytes in peripheral blood and serum concentrations of soluble interleukin 6 receptor are increased in patients with Graves' orbitopathy and correlate with disease activity.
Slowik M; Urbaniak-Kujda D; Bohdanowicz-Pawlak A; Kapelko-Slowik K; Dybko J; Wolowiec D; Jazwiec B; Daroszewski J
Endocr Res; 2012; 37(2):89-95. PubMed ID: 22489922
[TBL] [Abstract][Full Text] [Related]
49. Interleukin-12B gene polymorphism does not confer susceptibility to Graves' ophthalmopathy in Japanese population.
Hiromatsu Y; Fukutani T; Ichimura M; Mukai T; Kaku H; Miyake I; Yamada K
Endocr J; 2006 Dec; 53(6):753-9. PubMed ID: 16966828
[TBL] [Abstract][Full Text] [Related]
50. The VDR gene confers a genetic predisposition to Graves' disease and Graves' ophthalmopathy in the Southwest Chinese Han population.
Zhou F; Liang Z; Wang X; Tan G; Wei W; Zheng G; Ma X; Tian D; Li H; Yu H
Gene; 2021 Aug; 793():145750. PubMed ID: 34077777
[TBL] [Abstract][Full Text] [Related]
51. Interleukin-13 gene polymorphisms in patients with Graves' disease.
Bednarczuk T; Placha G; Jazdzewski K; Kurylowicz A; Kloza M; Makowska U; Hiromatsu Y; Nauman J
Clin Endocrinol (Oxf); 2003 Oct; 59(4):519-25. PubMed ID: 14510917
[TBL] [Abstract][Full Text] [Related]
52. Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.
Daroszewski J; Pawlak E; Karabon L; Frydecka I; Jonkisz A; Slowik M; Bolanowski M
Eur J Endocrinol; 2009 Nov; 161(5):787-93. PubMed ID: 19734241
[TBL] [Abstract][Full Text] [Related]
53. Association of MBL2 gene exon 1 variants with autoimmune thyroid disease in Brazilian patients.
Filho CB; Rodrigues FF; Segat L; Fonseca AM; Araujo J; Arahata C; Pontes L; Vilar L; de Lima Filho JL; Crovella S
Int J Immunogenet; 2012 Aug; 39(4):357-61. PubMed ID: 22360648
[TBL] [Abstract][Full Text] [Related]
54. The A946T polymorphism in the interferon induced helicase gene does not confer susceptibility to Graves' disease in Chinese population.
Zhao ZF; Cui B; Chen HY; Wang S; Li I; Gu XJ; Qi L; Li XY; Ning G; Zhao YJ
Endocrine; 2007 Oct; 32(2):143-7. PubMed ID: 18026693
[TBL] [Abstract][Full Text] [Related]
55. Thymic stromal lymphopoietin gene promoter polymorphisms and expression levels in Graves' disease and Graves' ophthalmopathy.
Tsai KH; Tsai FJ; Lin HJ; Lin HJ; Liu YH; Liao WL; Wan L
BMC Med Genet; 2012 Nov; 13():116. PubMed ID: 23194010
[TBL] [Abstract][Full Text] [Related]
56. Association of variant on the promoter of cluster of differentiation 74 in graves disease and graves ophthalmopathy.
Liu YH; Shen CY; Tsai FJ
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744317
[TBL] [Abstract][Full Text] [Related]
57. Association of TLR7 and TSHR copy number variation with Graves' disease and Graves' ophthalmopathy in Chinese population in Taiwan.
Liao WL; Wan L; Wang TY; Chen CC; Tse SS; Lu CH; Tsai FJ
BMC Ophthalmol; 2014 Feb; 14():15. PubMed ID: 24517461
[TBL] [Abstract][Full Text] [Related]
58. Both interleukin-23A polymorphism and serum interlukin-23 expression are associated with Graves' disease risk.
Jia H; Tao F; Liu C; Guo T; Zhu W; Wang S; Cui B; Ning G
Cell Immunol; 2015 Mar; 294(1):39-43. PubMed ID: 25670394
[TBL] [Abstract][Full Text] [Related]
59. Serum pro- and anti-inflammatory cytokines in patients with Graves' disease with ophthalmopathy during treatment with glucocorticoids.
Myśliwiec J; Kretowski A; Szelachowska M; Mikita A; Kinalska I
Rocz Akad Med Bialymst; 1999; 44():160-9. PubMed ID: 10697431
[TBL] [Abstract][Full Text] [Related]
60. The association of thyroid peroxidase antibody risk loci with susceptibility to and phenotype of Graves' disease.
Kuś A; Szymański K; Peeters RP; Miśkiewicz P; Porcu E; Pistis G; Sanna S; Naitza S; Płoski R; Medici M; Bednarczuk T
Clin Endocrinol (Oxf); 2015 Oct; 83(4):556-62. PubMed ID: 25345847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
